Echo Therapeutics Inc (NASDAQ:ECTE)

1.62
Delayed Data
As of May 22
 -0.03 / -1.82%
Today’s Change
0.39
Today|||52-Week Range
3.00
+20.00%
Year-to-Date
No recent news for Echo Therapeutics Inc.

Today’s Trading

Previous close1.65
Today’s open1.68
Day’s range-- - --
Volume49,223
Average volume (3 months)60,027
Market cap$18.0M
Dividend yield--
Data as of 05/22/2015

Growth & Valuation

Earnings growth (last year)+46.78%
Earnings growth (this year)-37.10%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+107.68%
P/E ratioNM
Price/Sales289.88
Price/Book2.16

Competitors

 Today’s
change
Today’s
% change
BSPMBiostar Pharmaceutic...+0.01+0.88%
KBIOKaloBios Pharmaceuti...-0.02-3.59%
RTGNRuthigen Inc+0.02+0.50%
ABIOARCA Biopharma Inc+0.01+1.32%
Data as of 05/22/2015

Financials

Last reporting dateApril 15, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$57.3K
Annual profit (last year)-$15.0M
Net profit margin-26,103.27%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Scott Wayne Hollander
Vice President-Operations &
Product Development
Thomas H. Bishop
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers